Skip to content

Circles

O

Oaktree Acquisition Corp. III Life Sciences

OACCU· Nasdaq

O

OACCUOaktree Acquisition Corp. III Life Sciences

OACCUOaktree Acquisition Corp. III Life Sciences·Earnings record

Q3 2024

Source filing unavailable

Next · Q1 2025

Q3 2024 · —

Revenue—

Net Income

-$48.10K

no prior Q3 2023 on file

EPS, diluted—

Operating Income-$48,095—

Operating Cash Flow$0—

Same quarter

no prior Q3 2023 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q3 ’24Q1 ’25 Q2 ’25 Q3 ’25 Q4 ’25^d Q1 ’26 Q2 ’26

Oaktree Acquisition Corp. III Life Sciences · CIK 2029769 · Engraved from SEC EDGAR

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy